M. Pfeiffer

发表

Combination therapy with tacrolimus and mycophenolate mofetil following cardiac transplantation: importance of mycophenolic acid therapeutic drug monitoring.

H. Reichenspurner, B. Meiser, B. Reichart, 1999, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

The efficacy of the combination of tacrolimus and mycophenolate mofetil for prevention of acute myocardial rejection is dependent on routine monitoring of mycophenolic acid trough acid levels.

H. Reichenspurner, B. Meiser, B. Reichart, 1999, Transplantation proceedings.

REDUCTION OF CYCLOSPORINE‐INDUCED NEPHROTOXICITY BY CILASTATIN FOLLOWING CLINICAL HEART TRANSPLANTATION1

H. Reichenspurner, B. Reichart, A. Markewitz, 1994, Transplantation.

Changes of resorption and metabolism of cyclosporine after heart transplantation by the influence of gastrointestinal agents.

H. Reichenspurner, B. Meiser, B. Reichart, 1994, Transplantation proceedings.

Experience with the Novacor left ventricular assist system as a bridge to cardiac transplantation, including the new wearable system.

B. Reichart, P. Uberfuhr, O. Dewald, 1995, The Journal of thoracic and cardiovascular surgery.

Tacrolimus: a superior agent to OKT3 for treating cases of persistent rejection after intrathoracic transplantation.

H. Reichenspurner, B. Meiser, B. Reichart, 1997, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Single-center randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of acute myocardial rejection.

H. Reichenspurner, B. Meiser, B. Reichart, 1998, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Cyclosporine versus tacrolimus (FK 506) for prevention of cardiac allograft vasculopathy.

U. Siebert, B. Meiser, B. Reichart, 2000, The American journal of cardiology.

Diabetic microangiopathy and blood viscosity changes after pancreas and kidney transplantation.

D. Abendroth, R. Landgraf, W. Land, 1994, Transplantation proceedings.

MMF-DOSE ADJUSTMENTS BASED ON MPA-TROUGH LEVELS AFTER HEART TRANSPLANTATION: DIFFERENCE BETWEEN HIGH AND LOW DOSE PHARMACOKINETICS

B. Meiser, B. Reichart, D. Paulus, 1999 .

Hyperimmunoglobulin prophylaxis, monitoring and preemptive ganciclovir treatment eliminate the risk of CMV infection to improve patient and renal allograft survival

B. Zanker, W. Land, W. Illner, 2000, Transplant international : official journal of the European Society for Organ Transplantation.

Renal function in the postoperative period after orthotopic liver transplantation.

M. Haller, J. Briegel, U. Finsterer, 1992, Transplantation proceedings.

Brief report: Safety of ciprofloxacin based on phase IV studies (“Anwendungsbeobachtung”) in the Federal Republic of Germany

M. Pfeiffer, C. Reiter, R. Hullman, 1989 .